Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations
- PMID: 15328104
- PMCID: PMC514730
- DOI: 10.1128/AAC.48.9.3407-3411.2004
Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations
Abstract
Resistance problems with caspofungin, an echinocandin inhibitor of fungal cell wall glucan synthesis, have been rare. We noted paradoxical turbid growth of Candida albicans isolates in broth in some high (supra-MIC) concentrations. Among isolates submitted for susceptibility testing and screened at drug concentrations up to 12.5 microg/ml, the frequency was 16%. Analysis of the turbid growth indicated slowing of growth in the presence of drug but with numbers of CFU up to 72% those of drug-free controls. Clearing of growth again by the highest drug concentrations produced a quadriphasic pattern in a tube dilution series. Cells growing at high drug concentrations were not resistant on retesting but showed the paradoxical effect of the parent. Among a selected series of isolates tested at concentrations up to 50 microg/ml, an additional 53% showed a "mini-paradoxical effect": no turbid growth but incomplete killing at high concentrations (supra-minimum fungicidal concentration). These effects were reproducible; medium dependent in extent; noted in macro- and microdilution, in the presence or absence of serum, and on agar containing drug (but not when drug concentrations were not constant, as in agar diffusion); not seen with other echinocandins and less commonly in other Candida species; and not due to destruction of drug in tubes showing the effect. Cooperative enhancement of inhibition by a second drug could eradicate the effect. We postulate that high drug concentrations derepress or activate resistance mechanisms. The abilities of subpopulations to survive at high drug concentrations could have in vivo consequences.
Similar articles
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
The echinocandins.Pharmacotherapy. 2007 Mar;27(3):369-88. doi: 10.1592/phco.27.3.369. Pharmacotherapy. 2007. PMID: 17316149 Review.
-
Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.Antimicrob Agents Chemother. 2006 Sep;50(9):3160-1. doi: 10.1128/AAC.00563-06. Antimicrob Agents Chemother. 2006. PMID: 16940118 Free PMC article.
-
Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.Antimicrob Agents Chemother. 2005 Aug;49(8):3264-73. doi: 10.1128/AAC.49.8.3264-3273.2005. Antimicrob Agents Chemother. 2005. PMID: 16048935 Free PMC article. Clinical Trial.
-
Studies of the paradoxical effect of caspofungin at high drug concentrations.Diagn Microbiol Infect Dis. 2005 Mar;51(3):173-8. doi: 10.1016/j.diagmicrobio.2004.10.006. Diagn Microbiol Infect Dis. 2005. PMID: 15766602
Cited by
-
New Vision of Cell Walls in Aspergillus fumigatus from Solid-State NMR Spectroscopy.J Fungi (Basel). 2024 Mar 16;10(3):219. doi: 10.3390/jof10030219. J Fungi (Basel). 2024. PMID: 38535227 Free PMC article. Review.
-
In Vitro Susceptibility Tests in the Context of Antifungal Resistance: Beyond Minimum Inhibitory Concentration in Candida spp.J Fungi (Basel). 2023 Dec 12;9(12):1188. doi: 10.3390/jof9121188. J Fungi (Basel). 2023. PMID: 38132789 Free PMC article. Review.
-
Candida albicans exhibits heterogeneous and adaptive cytoprotective responses to antifungal compounds.Elife. 2023 Oct 27;12:e81406. doi: 10.7554/eLife.81406. Elife. 2023. PMID: 37888959 Free PMC article.
-
Caspofungin-induced β(1,3)-glucan exposure in Candida albicans is driven by increased chitin levels.mBio. 2023 Aug 31;14(4):e0007423. doi: 10.1128/mbio.00074-23. Epub 2023 Jun 28. mBio. 2023. PMID: 37377417 Free PMC article.
-
Effect of new methionine-based ionic liquid on the CDR1 and CDR2 gene expression on sensitive and resistant strains of Candida albicans.Iran J Microbiol. 2023 Apr;15(2):325-335. doi: 10.18502/ijm.v15i2.12485. Iran J Microbiol. 2023. PMID: 37193238 Free PMC article.
References
-
- Denning, D. W., L. H. Hanson, A. M. Perlman, and D. A. Stevens. 1992. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagn. Microbiol. Infect. Dis. 15:21-34. - PubMed
-
- Deresinski, S. C., and D. A. Stevens. 2003. Caspofungin. Clin. Infect. Dis. 36:1445-1457. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources